AU2025287416A1 — Compositions for the treatment of hypertension
Assigned to George Institute for Global Health · Expires 2026-01-22 · 0y expired
What this patent protects
COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
USPTO Abstract
COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
Drugs covered by this patent
- Caduet (Amlodipine Besylate) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.